New device use updates on French agency website:
This article was originally published in Clinica
Executive Summary
Recent medical device updates featured on the website of the French healthcare product safety agency AFSSaPS concern Ela Medical's Alto implantable defibrillators and Gambro's Select Bags for glucose used in haemodialysis. Ela Medical is informing doctors responsible for the follow-up of patients receiving its Alto devices that it now has a new version software programme for the defibrillator which will help during the three-month follow-up of patients to check the performance of the batteries, which have given cause for concern in the past. Gambro's update concerns the handling of the haemodialysis concentrate in double compartment Select Bags.